Cardiac Surgery Peer Recovery Support Program
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology, Cardiology, Psychiatric |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/17/2019 |
| Start Date: | September 3, 2018 |
| End Date: | December 2019 |
| Contact: | David Goede, DNP ACNP-BC |
| Email: | mailto:David_Goede@URMC.Rochester.edu |
| Phone: | 585-276-5640 |
The purpose of the study is to develop and implement an addiction recovery support program
for cardiac surgery patients admitted with a diagnosis of infective endocarditis secondary to
IV drug addiction.
This is a single center/single unit (7-3600) exploratory study to examine the efficacy of
three interventions on a subject's SOCRATES 8D score at time of discharge, at three months,
and at six months. A convenience sample of all patients admitted to 7-3600 who meet the
inclusion criteria for this study will be approached and provided information related to this
study. Once entered into the study, the subjects will continue in the study through their
hospitalizations and up to 60 days post hospitalization.
This is a quality improvement study designed specifically for the cardiac surgery population.
The unit is the primary unit that subjects who are admitted with IE are located. The study's
objectives include:
By date of discharge, subjects enrolled in the Peer Recovery Support Program will:
1. Actively engage in the program as defined by meeting with a Peer Support Volunteer at
least two times prior to discharge, and or use of resilience journal, and or review of
NA book.
2. Demonstrate negative drug screens done randomly during their hospitalization.
3. Actively contact at least one outpatient recovery program that they might enroll in
prior to discharge (information about recovery programs to be provided by unit SW).
4. Demonstrate appropriate changes in their SOCRATES 8D survey scores from admission to
program to post discharge.
5. Participate in follow up phone call with completion of SOCRATES 8D survey at 30 and 60
days post discharge.
for cardiac surgery patients admitted with a diagnosis of infective endocarditis secondary to
IV drug addiction.
This is a single center/single unit (7-3600) exploratory study to examine the efficacy of
three interventions on a subject's SOCRATES 8D score at time of discharge, at three months,
and at six months. A convenience sample of all patients admitted to 7-3600 who meet the
inclusion criteria for this study will be approached and provided information related to this
study. Once entered into the study, the subjects will continue in the study through their
hospitalizations and up to 60 days post hospitalization.
This is a quality improvement study designed specifically for the cardiac surgery population.
The unit is the primary unit that subjects who are admitted with IE are located. The study's
objectives include:
By date of discharge, subjects enrolled in the Peer Recovery Support Program will:
1. Actively engage in the program as defined by meeting with a Peer Support Volunteer at
least two times prior to discharge, and or use of resilience journal, and or review of
NA book.
2. Demonstrate negative drug screens done randomly during their hospitalization.
3. Actively contact at least one outpatient recovery program that they might enroll in
prior to discharge (information about recovery programs to be provided by unit SW).
4. Demonstrate appropriate changes in their SOCRATES 8D survey scores from admission to
program to post discharge.
5. Participate in follow up phone call with completion of SOCRATES 8D survey at 30 and 60
days post discharge.
In 2015, Cardiac Surgery service at the University of Rochester Medical Center surgically
treated 33 patients with IE. Of these 33, 12 patients had a history of IV drug use prior to
their admission. Five patients had recent IV drug use which is defined as use less than 30
days prior to admission. In 2016, Cardiac Surgery service surgically treated 41 patients with
endocarditis. Of these 41, 20 patients had a history of recent IV drug use prior to their
admission. Nine patients had recent IVDU. In 2017, IE admissions did decrease, 16 patients
with IE were surgically treated. Of these, 6 patients had recent IVDU prior to admission
(Figure 3) (P. Krause, personal communication, 12/20/2017). These numbers only represent the
patients that had undergone surgical repair/replacement of their cardiac valves and thus do
not include the patients that were admitted to the cardiac surgery service, medically
managed, and then transferred or discharged to home.
The investigators do not have a total number of target subjects due to the variability of
admissions with IE. The goal is to have at least 10 subjects enrolled and complete all follow
ups.
1. Inclusion Criteria:
All patients considered for this program must meet the following criteria:
1. Must be at least 18 years of age and able to provide consent
2. Must speak/read/understand English
3. Currently hospitalized and physically located on 7-3600 unit
4. Followed by or on the Cardiac Surgery service
5. Have a diagnosis of Endocarditis associated with recent or remote intravenous drug
use (IVDU)
6. Alert and oriented to person, place, time, and events leading up to hospitalization
7. Able to carry on a coherent conversation
8. Clinical Opiate Withdrawal (COW) score of less than or equal to 5 with no
adjunctive (opioids) medication use within past 24 hours a. If COW score is greater
than five or adjunctive medications have been used within the previous 24 hours,
the patient will be re-evaluate every 24 hours until score is less than or equal to
five and no adjunctive medications used within the previous 24 hours
2. Exclusion Criteria:
1. Under the age of 18 years old
2. Unable to speak/read/understand English
3. Hospitalized but not on 7-3600
4. Does not have a diagnosis of endocarditis associated with IVDU
5. Not followed by or on the Cardiac Surgery service
6. Not Alert or oriented or unable to carry on a coherent conversation
7. COW score that is greater than five or adjunctive medications have been used within
the previous 24 hours (see inclusion criteria)
treated 33 patients with IE. Of these 33, 12 patients had a history of IV drug use prior to
their admission. Five patients had recent IV drug use which is defined as use less than 30
days prior to admission. In 2016, Cardiac Surgery service surgically treated 41 patients with
endocarditis. Of these 41, 20 patients had a history of recent IV drug use prior to their
admission. Nine patients had recent IVDU. In 2017, IE admissions did decrease, 16 patients
with IE were surgically treated. Of these, 6 patients had recent IVDU prior to admission
(Figure 3) (P. Krause, personal communication, 12/20/2017). These numbers only represent the
patients that had undergone surgical repair/replacement of their cardiac valves and thus do
not include the patients that were admitted to the cardiac surgery service, medically
managed, and then transferred or discharged to home.
The investigators do not have a total number of target subjects due to the variability of
admissions with IE. The goal is to have at least 10 subjects enrolled and complete all follow
ups.
1. Inclusion Criteria:
All patients considered for this program must meet the following criteria:
1. Must be at least 18 years of age and able to provide consent
2. Must speak/read/understand English
3. Currently hospitalized and physically located on 7-3600 unit
4. Followed by or on the Cardiac Surgery service
5. Have a diagnosis of Endocarditis associated with recent or remote intravenous drug
use (IVDU)
6. Alert and oriented to person, place, time, and events leading up to hospitalization
7. Able to carry on a coherent conversation
8. Clinical Opiate Withdrawal (COW) score of less than or equal to 5 with no
adjunctive (opioids) medication use within past 24 hours a. If COW score is greater
than five or adjunctive medications have been used within the previous 24 hours,
the patient will be re-evaluate every 24 hours until score is less than or equal to
five and no adjunctive medications used within the previous 24 hours
2. Exclusion Criteria:
1. Under the age of 18 years old
2. Unable to speak/read/understand English
3. Hospitalized but not on 7-3600
4. Does not have a diagnosis of endocarditis associated with IVDU
5. Not followed by or on the Cardiac Surgery service
6. Not Alert or oriented or unable to carry on a coherent conversation
7. COW score that is greater than five or adjunctive medications have been used within
the previous 24 hours (see inclusion criteria)
Inclusion Criteria:
All patients considered for this program must meet the following criteria:
1. Must be at least 18 years of age and able to provide consent
2. Must speak/read/understand English
3. Currently hospitalized and physically located on 7-3600 unit
4. Followed by or on the Cardiac Surgery service
5. Have a diagnosis of Endocarditis associated with recent or remote intravenous drug use
(IVDU)
6. Alert and oriented to person, place, time, and events leading up to hospitalization
7. Able to carry on a coherent conversation
8. Clinical Opiate Withdrawal (COW) score of less than or equal to 5 with no adjunctive
(opioids) medication use within past 24 hours a. If COW score is greater than five or
adjunctive medications have been used within the previous 24 hours, the patient will
be re-evaluate every 24 hours until score is less than or equal to five and no
adjunctive medications used within the previous 24 hours
Exclusion Criteria:
1. Under the age of 18 years old
2. Unable to speak/read/understand English
3. Hospitalized but not on 7-3600
4. Does not have a diagnosis of endocarditis associated with IVDU
5. Not followed by or on the Cardiac Surgery service
6. Not Alert or oriented or unable to carry on a coherent conversation
7. COW score that is greater than five or adjunctive medications have been used within
the previous 24 hours (see inclusion criteria)
We found this trial at
1
site
601 Elmwood Avenue
Rochester, New York 14642
Rochester, New York 14642
(585) 275-2100
Phone: 585-275-5276
Univ of Rochester Medical Center One of the nation's top academic medical centers, the University...
Click here to add this to my saved trials
